Tojo Thomas is a Gastroenterology physician. OpenAlex indexes 11 publications with 368 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12121 Richmond Ave
Suite 424
Houston, TX 770822432
Telephone
832-379-8603Registry record last updated 5 Jul 2011.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202513 payments
- Ardelyx, Inc.Program year20253 payments
- Aimmune Therapeutics, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
88.6%Proton pump inhibitor32%Omeprazole64%Pantoprazole Sodium28%Esomeprazole Magnesium6%Lansoprazole2%Part D<11 patientsAluminum Complex19.6%Sucralfate100%Part D≥129 patients+ 12 more classes in this area
Cardiovascular
4.4%Bile Acid Sequestrant2%Cholestyramine Light72%Cholestyramine28%Part D<11 patientsBeta blocker0.9%Propranolol Hcl100%Part D<11 patients+ 2 more classes in this area
Sensory organs
3.5%Corticosteroid2.9%Hydrocortisone71%Procto-Med Hc29%Part D<11 patientsTetracycline-class Antimicrobial0.6%Tetracycline Hcl100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rifaximin Is Effective for the Treatment of<i>Clostridium difficile</i>—Associated Diarrhea: Results of an Open-Label Pilot Study
Gastroenterology Research and Practice
2011 - Do CT Enterography Findings Correlate with Clinical Scores of Crohnʼs Disease?
The American Journal of Gastroenterology
2011
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”